{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:07:54Z","timestamp":1763507274524,"version":"3.45.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2021-1-I2M-016"],"award-info":[{"award-number":["2021-1-I2M-016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03297-7","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:49:14Z","timestamp":1763462954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative risk model and nomogram for 30\u2011Day mortality after TAVR: development and internal validation in a Chinese cohort"],"prefix":"10.1186","volume":"25","author":[{"given":"Haochao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongquan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"10","key":"3297_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/eurheartj\/ehac803","volume":"44","author":"G Lee","year":"2023","unstructured":"Lee G, Chikwe J, Milojevic M, et al. ESC\/EACTS vs. ACC\/AHA guidelines for the management of severe aortic stenosis. Eur Heart J. 2023;44(10):796\u2013812. https:\/\/doi.org\/10.1093\/eurheartj\/ehac803.","journal-title":"Eur Heart J"},{"issue":"10436","key":"3297_CR2","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0140-6736(23)02755-1","volume":"403","author":"F Praz","year":"2024","unstructured":"Praz F, Beyersdorf F, Haugaa K, Prendergast B. Valvular heart disease: from mechanisms to management. Lancet. 2024;403(10436):1576\u201389. https:\/\/doi.org\/10.1016\/S0140-6736(23)02755-1.","journal-title":"Lancet"},{"issue":"1","key":"3297_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jamacardio.2015.0326","volume":"1","author":"FH Edwards","year":"2016","unstructured":"Edwards FH, et al. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol. 2016;1(1):46\u201352. https:\/\/doi.org\/10.1001\/jamacardio.2015.0326.","journal-title":"JAMA Cardiol"},{"issue":"21","key":"3297_CR4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","volume":"76","author":"JD Carroll","year":"2020","unstructured":"Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76(21):2492\u2013516. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.595.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3297_CR5","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72\u2013227. https:\/\/doi.org\/10.1161\/CIR.0000000000000923.","journal-title":"Circulation"},{"issue":"16","key":"3297_CR6","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jacc.2020.08.048","volume":"76","author":"SA Hirji","year":"2020","unstructured":"Hirji SA, Percy ED, McGurk S, et al. Incidence, characteristics, predictors, and outcomes of surgical explantation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76(16):1848\u201359. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.048.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3297_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jcin.2024.02.014","volume":"17","author":"NS Kleiman","year":"2024","unstructured":"Kleiman NS, Van Mieghem NM, Reardon MJ, et al. Quality of life 5 years following transfemoral TAVR or SAVR in intermediate risk patients. JACC Cardiovasc Interv. 2024;17(8):979\u201388. https:\/\/doi.org\/10.1016\/j.jcin.2024.02.014.","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"3297_CR8","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2025.03.004","volume":"85","author":"JK Forrest","year":"2025","unstructured":"Forrest JK, Yakubov SJ, Deeb GM, et al. 5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis. J Am Coll Cardiol. 2025;85(15):1523\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2025.03.004.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3297_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11788-3","volume":"12","author":"N Corcione","year":"2022","unstructured":"Corcione N, Morello A, Ferraro P, et al. TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation. Sci Rep. 2022;12(1):7612. https:\/\/doi.org\/10.1038\/s41598-022-11788-3.","journal-title":"Sci Rep"},{"issue":"11","key":"3297_CR10","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jcin.2021.03.024","volume":"14","author":"EP Navarese","year":"2021","unstructured":"Navarese EP, Zhang Z, Kubica J, et al. Development and validation of a practical model to identify patients at risk of bleeding after TAVR. JACC Cardiovasc Interv. 2021;14(11):1196\u2013206. https:\/\/doi.org\/10.1016\/j.jcin.2021.03.024.","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"3297_CR11","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1161\/CIR.0000000000000031","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease. Circulation. 2014;129(23):e521\u2013643. https:\/\/doi.org\/10.1161\/CIR.0000000000000031.","journal-title":"Circulation"},{"issue":"3","key":"3297_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00392-020-01731-9","volume":"110","author":"G Wolff","year":"2021","unstructured":"Wolff G, Shamekhi J, Al-Kassou B, et al. Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients. Clin Res Cardiol. 2021;110(3):368\u201376. https:\/\/doi.org\/10.1007\/s00392-020-01731-9.","journal-title":"Clin Res Cardiol"},{"key":"3297_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.carrev.2025.02.011","volume":"74","author":"N Chan","year":"2025","unstructured":"Chan N, Agrawal A, Arockiam AD, et al. Contemporary risk models for transcatheter aortic valve replacement: a narrative review. Cardiovasc Revasc Med. 2025;74:71\u20139. https:\/\/doi.org\/10.1016\/j.carrev.2025.02.011.","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"3297_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.21037\/acs.2017.07.01","volume":"6","author":"S Arora","year":"2017","unstructured":"Arora S, Vavalle JP. Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence. Ann Cardiothorac Surg. 2017;6(5):493\u20137. https:\/\/doi.org\/10.21037\/acs.2017.07.01.","journal-title":"Ann Cardiothorac Surg"},{"key":"3297_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijcard.2020.05.039","volume":"317","author":"H Al-Farra","year":"2020","unstructured":"Al-Farra H, Abu-Hanna A, de Mol BAJM, et al. External validation of existing prediction models of 30-day mortality after transcatheter aortic valve implantation (TAVI) in the Netherlands heart registration. Int J Cardiol. 2020;317:25\u201332. https:\/\/doi.org\/10.1016\/j.ijcard.2020.05.039.","journal-title":"Int J Cardiol"},{"key":"3297_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijcard.2016.08.260","volume":"223","author":"JF Condado","year":"2016","unstructured":"Condado JF, Junpaparp P, Binongo JN, et al. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR). Int J Cardiol. 2016;223:444\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.260.","journal-title":"Int J Cardiol"},{"issue":"3","key":"3297_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/ehjdh\/ztad021","volume":"4","author":"A Leha","year":"2023","unstructured":"Leha A, Huber C, Friede T, et al. Development and validation of explainable machine learning models for risk of mortality in transcatheter aortic valve implantation: TAVI risk machine scores. Eur Heart J. 2023;4(3):225\u201335. https:\/\/doi.org\/10.1093\/ehjdh\/ztad021.","journal-title":"Eur Heart J"},{"issue":"4","key":"3297_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jjcc.2024.07.009","volume":"85","author":"K Yamashita","year":"2025","unstructured":"Yamashita K, Maeda K, Pak K, et al. A risk model of mortality rate in dialysis patients following transcatheter aortic valve replacement. J Cardiol. 2025;85(4):329\u201333. https:\/\/doi.org\/10.1016\/j.jjcc.2024.07.009.","journal-title":"J Cardiol"},{"issue":"10","key":"3297_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101642","volume":"8","author":"V Veulemans","year":"2019","unstructured":"Veulemans V, Polzin A, Maier O, et al. Prediction of one-year mortality based upon a new staged mortality risk model in patients with aortic stenosis undergoing transcatheter valve replacement. J Clin Med. 2019;8(10):1642. https:\/\/doi.org\/10.3390\/jcm8101642.","journal-title":"J Clin Med"},{"issue":"14","key":"3297_CR20","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.jcin.2019.06.013","volume":"12","author":"DF Hernandez-Suarez","year":"2019","unstructured":"Hernandez-Suarez DF, Kim Y, Villablanca P, et al. Machine learning prediction models for in-hospital mortality after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12(14):1328\u201338. https:\/\/doi.org\/10.1016\/j.jcin.2019.06.013.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3297_CR21","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.athoracsur.2017.05.067","volume":"104","author":"J Forcillo","year":"2017","unstructured":"Forcillo J, Condado JF, Ko YA, et al. Assessment of commonly used frailty markers for high- and extreme-risk patients undergoing transcatheter aortic valve replacement. Ann Thorac Surg. 2017;104(6):1939\u201346. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.05.067.","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"3297_CR22","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s00259-019-04523-0","volume":"47","author":"Y Kadoya","year":"2020","unstructured":"Kadoya Y, Zen K, Tamaki N, et al. Early effects of transcatheter aortic valve replacement on cardiac sympathetic nervous function assessed by 123I-metaiodobenzylguanidine scintigraphy in patients with severe aortic valve stenosis. Eur J Nucl Med Mol Imaging. 2020;47(7):1657\u201367. https:\/\/doi.org\/10.1007\/s00259-019-04523-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"22","key":"3297_CR23","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jcin.2019.06.020","volume":"12","author":"J Chahine","year":"2019","unstructured":"Chahine J, Kadri AN, Gajulapalli RD, et al. Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease. JACC Cardiovasc Interv. 2019;12(22):2299\u2013306. https:\/\/doi.org\/10.1016\/j.jcin.2019.06.020.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03297-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:03:51Z","timestamp":1763507031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-025-03297-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3297"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03297-7","relation":{},"ISSN":["1471-2482"],"issn-type":[{"type":"electronic","value":"1471-2482"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the principles of the Helsinki Declaration and the Measures for Ethical Review of Biomedical Research Involving Humans. The protocol was reviewed and approved by the Ethics Committee of Fuwai Hospital (Approval No. 2023-2005). Informed consent was waived because of the retrospective nature of the study and anonymized data processing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"557"}}